Cargando cotizaciones...
Previsión
El precio objetivo medio de los analistas es de 30,17 € (-3,61 %). La mediana es de 28,13 € (-10,13 %).
| Comprar |
8 |
| Mantener |
7 |
| Vender |
0 |
Debates en la comunidad
Todavía no hay ninguna discusión sobre este activo.
Iniciar debateNoticias Ir al feed de noticias
Double downgrade drives Trupanion stock sharply lower
The stock of Trupanion fell about 6.4% in morning trading after Piper Sandler cut its rating from "Overweight" to "Neutral" and lowered the price target from $45 to $32. Piper Sandler cited declining puppy vet visits and more costly, aging COVID cohorts as headwinds for premium growth and underwriting margins. A simultaneous downgrade by Zacks intensified the sell-off, while the new price target, near the current share price, signals only limited short-term upside. » Más en de.investing.com
Trupanion beats Q2 earnings forecast and highlights outlook for 2026
Trupanion reported Q2/2026 earnings of $0.16 per share, beating the $0.1133 forecast, on revenue up 11% to $392.9m. Adjusted operating income from subscriptions rose 24% and subscription revenue grew 14% to $276.7m, while the number of insured pets increased 5% to 1.125m. The stock rose 6.7% after hours; management confirmed a 2026 revenue range of $1.584–1.601bn and adjusted operating income of $176–184m. Risks remain higher customer acquisition costs, ongoing veterinary price inflation and execution risks for new product options. » Más en de.investing.com
Trupanion reaches 52-week low at $24.13
Trupanion shares fell to a 52-week low of $24.13 after losing about 34% over the past year and roughly 40% in recent months. For Q4 2025 the company reported earnings per share of $0.13 (forecast $0.16) and revenue of $376.9 million (+12% year over year), slightly beating expectations. Analysts cut price targets (Cantor Fitzgerald 42→34 USD, Stifel 35→31 USD) citing growth and scaling concerns, while InvestingPro signaled possible undervaluation and upside; Trupanion also announced a research collaboration with the Human Animal Bond Research Institute. » Más en de.investing.com
Trupanion falls to 52-week low of $24.30
Trupanion shares hit a new 52-week low at $24.30, down about 31.7% year-to-date; the six-month performance is down nearly 38%. The company reported Q4 2025 EPS of $0.13 (expectation $0.16) on revenue of $376.9 million (+12% YoY, forecast $375.21 million). Analysts cut price targets (Cantor Fitzgerald 42 → 34 USD, Stifel 35 → 31 USD), citing growth and scaling issues, while InvestingPro sees an undervaluation of around 38% and expects profitability this year. Trupanion also announced a partnership with the Human Animal Bond Research Institute to support studies on human-animal relationships. » Más en de.investing.com
Trupanion hits 52-week low after sharp share decline
Trupanion shares closed at $24.49, marking a 52-week low after declines of 33.06% over the past year, 43% in six months and 31% year-to-date. Investors are worried about slowing growth and competitive pressure in the pet insurance industry, although a PEG of 0.19 suggests possible undervaluation. In Q4 2025, Trupanion missed the EPS expectation (0.13 vs. $0.16) while revenue rose 12% to $376.9 million; a partnership with the Human Animal Bond Research Institute was also announced. » Más en de.investing.com
Dividendos históricos Dividendos
Todas las métricas de dividendos Todas las métricasDatos financieros de la empresa
| (EUR) | septiembre de 2026 | YoY |
|---|---|---|
| Ingresos | 358,08 M | 14,52 % |
| Beneficio bruto | 61,36 M | 19,90 % |
| Beneficio neto | 8,19 M | 63,74 % |
| EBITDA | 14,03 M | 22,48 % |
Datos fundamentales
| Métrica | Valor |
|---|---|
Capitalización bursátil | 1353,67 M € |
Número de acciones | 43,27 M |
Máximo/mínimo de 52 semanas | 35,27 € - 19,20 € |
| Dividendos | No |
Beta | 1,30 |
Ratio P/E | 56,52 |
Ratio PEG | 0,76 |
Ratio P/B | 3,77 |
Ratio P/S | 0,96 |
Perfil de la empresa
Trupanion, Inc., junto con sus filiales, ofrece seguros médicos para gatos y perros con suscripción mensual en Estados Unidos, Canadá, Puerto Rico y Australia. La empresa opera en dos segmentos, Subscription Business y Other Business. Atiende a dueños de mascotas y a veterinarios. La empresa era conocida anteriormente como Vetinsurance International, Inc. y cambió su nombre a Trupanion, Inc. en 2013. Fue fundada en 2000 y tiene su sede en Seattle, Washington.
| Nombre | Trupanion |
| CEO | Margaret Rosemary Maria Tooth |
| Sede | Seattle,
wa Estados Unidos |
| Sitio web | |
| Sector | Finanzas |
| Industria | Seguros |
| Salida a bolsa | 18/07/2014 |
| Empleados | 1121 |
Símbolos bursátiles
| Bolsa | Símbolo |
|---|---|
NASDAQ | TRUP |
London Stock Exchange | 0LH0.L |
Frankfurt | TPW.F |
Düsseldorf | TPW.DU |
London | 0LH0.L |
SIX | TPW.SW |
München | TPW.MU |